Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: A nationwide cohort study

CHIA-HSUIN CHANGJOU-WEI LINSHENG-YUAN RUANLee Y.-C.Wu L.-C.Lin M.-S.Lai M.-S.2020-10-152020-10-1520150263-6352https://www.scopus.com/inward/record.uri?eid=2-s2.0-84922475017&doi=10.1097%2fHJH.0000000000000438&partnerID=40&md5=61b09bc9822b8490e518ee5da427e731https://scholars.lib.ntu.edu.tw/handle/123456789/517126BACKGROUND[SDGs]SDG3captopril; dipeptidyl carboxypeptidase inhibitor; enalapril; fosinopril; imidapril; lisinopril; losartan; perindopril; ramipril; angiotensin receptor antagonist; captopril; dipeptidyl carboxypeptidase inhibitor; enalapril; losartan; ramipril; adult; Article; cohort analysis; dose response; female; hospitalization; human; hypertension; maintenance drug dose; major clinical study; male; meta analysis (topic); middle aged; mortality; outcome assessment; pneumonia; priority journal; sensitivity analysis; statistical significance; treatment duration; aged; comparative study; hospitalization; incidence; pneumonia; risk; Taiwan; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Enalapril; Female; Hospitalization; Humans; Incidence; Losartan; Male; Middle Aged; Pneumonia; Ramipril; Risk; TaiwanComparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: A nationwide cohort studyjournal article10.1097/HJH.0000000000000438254790252-s2.0-84922475017